{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:08:19Z","timestamp":1794589699741,"version":"4.9.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:p>Pathology-based screening of uterine smooth muscle tumors (uSMT) for morphology suggestive of fumarate hydratase deficiency (FH-d morphology) has been proposed as a method to identify women at increased risk for hereditary leiomyomatosis renal cell carcinoma (HLRCC) syndrome. For 5 years our clinical diagnostic practice has evaluated all women with any type of uSMT for FH-d morphology (defined, at low magnification, as staghorn shaped blood vessels and alveolar pattern edema and, at high magnification, as tumor macronucleoli surrounded by a halo and cytoplasmic eosinophilic globules) and, when present, used the pathology report to advise genetic counseling to further evaluate for HLRCC syndrome. We now report the results of this prospective screening strategy, with emphasis on the incidence and clinicopathologic features of FH-d morphology in uSMT, the rate of patient uptake of referral to genetic counseling, and the results of genetic testing for <jats:italic toggle=\"yes\">FH<\/jats:italic> germline mutation. Among 2060 women with a uSMT, FH-d morphology was reported in 1.4% (30 women). Ten women elected to undergo <jats:italic toggle=\"yes\">FH<\/jats:italic> genetic testing and 6 of 10 (60%) had a <jats:italic toggle=\"yes\">FH<\/jats:italic> germline mutation: 5 were pathogenic mutations and 1 was a mutation variant of unknown significance. Therefore, the screening program led to a confirmed genetic diagnosis of HLRCC syndrome in 0.24% of all women with any type of uSMT. The women with a pathogenic mutation were ages 24 to 40 years. Although the majority of leiomyoma with bizarre nuclei exhibited FH-d morphology, the uSMT were conventional leiomyomas with FH-d morphology in 2 of 5 women found to have a pathogenic <jats:italic toggle=\"yes\">FH<\/jats:italic> germline mutation. Relying on an abnormal FH immunostain result to trigger genetic counseling referral would have resulted in 2 of 5 (40%) cases with pathogenic <jats:italic toggle=\"yes\">FH<\/jats:italic> germline mutation but normal FH immunoexpression going undetected, both of which were missense type mutations. There was no difference in the incidence of pathogenic <jats:italic toggle=\"yes\">FH<\/jats:italic> germline mutation between FH-d morphology uSMT with an abnormal versus a normal FH immunostain result. Overall, this study demonstrates that prospective morphology-based screening, integrated with referral for genetic counseling, can result in the diagnosis of HLRCC syndrome in otherwise unselected women with uSMT. We conclude that this strategy should be incorporated in the routine pathologic examination of all uterine smooth muscle tumors.<\/jats:p>","DOI":"10.1097\/pas.0000000000001222","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T11:57:41Z","timestamp":1550231861000},"page":"639-655","source":"Crossref","is-referenced-by-count":48,"title":["Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome"],"prefix":"10.1097","volume":"43","author":[{"given":"Joseph T.","family":"Rabban","sequence":"first","affiliation":[{"name":"Pathology Department, University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chan","sequence":"additional","affiliation":[{"name":"Pathology Department, University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Mak","sequence":"additional","affiliation":[{"name":"Cancer Risk Program, Hellen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Zaloudek","sequence":"additional","affiliation":[{"name":"Pathology Department, University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna","family":"Garg","sequence":"additional","affiliation":[{"name":"Pathology Department, University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pathol.2017.10.009","article-title":"Uncommon hereditary gynaecological tumour syndromes: pathological features in tumours that may predict risk for a germline mutation","volume":"50","author":"Garg","year":"2018","journal-title":"Pathology"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/PAS.0000000000000520","article-title":"Morphology and immunohistochemistry for 2SC and FH aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients","volume":"39","author":"Joseph","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PAS.0b013e31825ec16f","article-title":"Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome","volume":"37","author":"Sanz-Ortega","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/cncr.30605","article-title":"Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma","volume":"123","author":"Kopp","year":"2017","journal-title":"Cancer"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00428-018-2292-6","article-title":"Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening","volume":"472","author":"Siegler","year":"2018","journal-title":"Virchows Arch"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/modpathol.2013.215","article-title":"Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry","volume":"27","author":"Reyes","year":"2014","journal-title":"Mod Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2133.2005.06678.x","article-title":"Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer","volume":"153","author":"Alam","year":"2005","journal-title":"Br J Dermatol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archderm.141.2.199","article-title":"Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome","volume":"141","author":"Alam","year":"2005","journal-title":"Arch Dermatol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmg.2005.033506","article-title":"Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer","volume":"43","author":"Wei","year":"2006","journal-title":"J Med Genet"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/PAS.0b013e318223ca01","article-title":"Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report","volume":"35","author":"Garg","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","article-title":"Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases","volume":"40","author":"Miettinen","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PGP.0000000000000091","article-title":"Current morphologic criteria perform poorly in identifying hereditary leiomyomatosis and renal cell carcinoma syndrome-associated uterine leiomyomas","volume":"33","author":"Alsolami","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment","volume":"13","author":"Menko","year":"2014","journal-title":"Fam Cancer"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/modpathol.2017.56","article-title":"Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma","volume":"40","author":"Smith","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pathol.2017.10.010","article-title":"Gynaecological neoplasms in common familial syndromes (Lynch and HBOC)","volume":"50","author":"Bartosch","year":"2018","journal-title":"Pathology"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jmg.2010.085068","article-title":"Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma","volume":"48","author":"Gardie","year":"2011","journal-title":"J Med Genet"},{"key":"R24-20230922","first-page":"223A","article-title":"Genetic alterations of uterine fibroids in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome (abstract 1021)","volume":"21(Suppl 1)","author":"Sanz","year":"2008","journal-title":"Mod Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/PAS.0000000000000626","article-title":"Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in cutaneous leiomyomas may aid in identification of patients with HLRCC (hereditary leiomyomatosis and renal cell carcinoma syndrome)","volume":"40","author":"Buelow","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R26-20230922","first-page":"411","article-title":"Patients with HLRCC have multiple leiomyomas with heterogeneous morphology that often show retained staining for fumarate hydratase (abstract 1147)","volume":"98(suppl 1)","author":"Chan","year":"2018","journal-title":"Lab Invest"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.annepidem.2007.10.011","article-title":"Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy","volume":"18","author":"Merrill","year":"2008","journal-title":"Ann Epidemiol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"425.e421","DOI":"10.1016\/j.ajog.2017.12.218","article-title":"Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women","volume":"218","author":"Morgan","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"428.e421","DOI":"10.1016\/j.ajog.2017.05.057","article-title":"Trends in hysterectomy rates among women veterans in the US Department of Veterans Affairs","volume":"217","author":"Katon","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1200\/JCO.2015.65.9557","article-title":"Randomized noninferiority trial of telephone delivery of BRCA1\/2 genetic counseling compared with in-person counseling: 1-year follow-up","volume":"34","author":"Kinney","year":"2016","journal-title":"J Clin Oncol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2014.06.009","article-title":"Consequences of universal MSI\/IHC in screening endometrial cancer patients for Lynch syndrome","volume":"134","author":"Batte","year":"2014","journal-title":"Gynecol Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201905000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:48:10Z","timestamp":1695422890000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201905000-00007"}},"subtitle":["A 5-Year Single Institutional Experience"],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001222","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}